Accessibility statements split sharply by origin
83% of US-origin beauty storefronts selling into the United States publish an accessibility statement against 37% of Korean-origin ones, a gap of 46 points, with US-origin brands the ones publishing.
An accessibility statement is the cheapest visible sign a US storefront has been through a compliance review, and a brand selling into the United States without one is not merely missing a page, it is usually a brand whose site nobody has audited, which is a live exposure in a market where web accessibility is litigated.
84 of a possible 90Tier B, systematic first-party observation. Nothing at this tier is allowed past 90, however good it looks.
Verified September 9, 2026Rechecked every 180 days, next by March 8, 2027.
Held since August 5, 2026How the market is physically or commercially arranged. The earliest date we are willing to say this held. It may well have been true before that; we do not backdate a record past the evidence we have read. Supported, version 1.
This entry is wrong if
A repeat run finds the two accessibility-page rates within 25 points of each other.
Written before the record was published, not after. If you can show this, send it to hello@tryorbt.com and the correction goes on the record with the entry.
Evidence
- Tier Bobserved-webn = 37
orbt: Market Register commerce collector, run commerce-20260805140548
Presence of a page whose handle names accessibility in the storefront’s own pages sitemap. Presence and not quality: this cannot tell a real conformance report from a paragraph saying accessibility matters, and both count here. What it does establish is whether the question was asked at all. A statement served from a footer overlay widget rather than a published page reads as absent. Retailers are excluded from both origin groups: OLIVE YOUNG Global, Peach & Lily, Soko Glam, Stylevana. Their catalogues are other companies’ product copy, so counting them by the storefront’s own origin would put Korean listings inside the US-origin group. Run commerce-20260805140548.
Read 2026-08-05 · CC BY · page hash
9a6ccfd5ea85
History
- v1created
Derived from collector run commerce-20260805053004.
Append-only. Nothing in this list is edited or removed once written, including the entries that record our own mistakes. Every change to every record is on the corrections page, and the same log is in entries.json under revisions.
Cite this entry
“Accessibility statements split sharply by origin”, The Orbt Market Index 0.1.0, entry omr:kr-us:accessibility-statements-split-by-origin, retrieved September 9, 2026, https://tryorbt.com/markets/entry/kr-us--accessibility-statements-split-by-origin. Dataset: https://doi.org/10.5281/zenodo.22679129
Orbt, "Accessibility statements split sharply by origin," Orbt Market Index, entry omr:kr-us:accessibility-statements-split-by-origin, verified September 9, 2026, https://tryorbt.com/markets/entry/kr-us--accessibility-statements-split-by-origin.
@misc{orbt-kr-us-accessibility-statements-split-by-origin,
title = {Accessibility statements split sharply by origin},
author = {{Orbt}},
year = {2026},
doi = {10.5281/zenodo.22679129},
note = {The Orbt Market Index 0.1.0 (dataset DOI 10.5281/zenodo.22679129), entry omr:kr-us:accessibility-statements-split-by-origin. Verified 2026-09-09},
howpublished = {\url{https://tryorbt.com/markets/entry/kr-us--accessibility-statements-split-by-origin}},
license = {Orbt Index Public Licence. Free to quote and cite; not to redistribute}
}For a deck, a brief or a chat.
Free to quote, cite and act on. Not to resell or redistribute — the sources ask that of us, and each one’s terms are named. Machine-readable: entries.json carries this record under the id omr:kr-us:accessibility-statements-split-by-origin, with the same evidence and falsifier.
Read next
Also true of the United States
What else we hold on this market, heaviest first.
- United StatesFacility registration renews every two years
- United StatesEvery product listed with FDA, ingredients included
- United StatesFDA can recall a cosmetic and suspend the facility
- United StatesA Korean plant is a US facility under MoCRA
- United StatesSerious adverse events report in 15 business days
- United StatesFDA registration is not FDA approval
Everything we hold on United StatesEvery record for this corridor